Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. Rev Diabet Stud. Published online June 12, 2026:62-76. doi:10.70082/y1zx3j95